A major direction of the field of organic synthesis is the integration ofits powerful techniques into the solution of problems that are directly relevant to medicine and biology. The major advantage of incorporating organic synthesis into these approaches is to provide access to compounds that are designed to study or probe a particular biological phenomenon and that cannot be obtained from natural or commercial sources. Organic chemists in recent years have increasingly realized the power oftheir field, and they have entered into productive collaborations with biologists and biochemists which have afforded unique insights into a number of biological processes. The fruits of one particularly notable collaboration are reported by Danishefsky, Schreiber, Crabtree, and their colleagues in this issue of the Proceedings (1) . This report elegantly demonstrates how basic chemical research into a group of natural products, the calicheamicins, when combined with some biochemical intuition, can open new avenues to investigate cellular processes.
Because of its unique biological activity, unusual chemical structure (Fig. 1) , and unprecedented mechanism of action, calicheamicin, arguably more than any other natural product, has spurred synthetic chemists to consider applying their knowledge to biological problems (2, 3) . Calicheamicin (4-7) is a member of the enediyne class of antibiotics, which also includes esperamicin, dynemicin, kedarcidin chromophore, C-1027 chromophore, and necarzinostatin chromophore (8) showed that calicheamicin binds in the minor groove (14) . The (18, 19) showed, through NMR studies, that calicheamicin adopts an extended, highly organized conformation in solution, making it well suited to function as a minor groove binder. They also demonstrated that the hydroxylamine glycosidic linkage plays a key role in maintaining this extended structure (20) .
That the oligosaccharide domain was crucial for selective and tight binding prior to cleavage was demonstrated by a series of experiments by Danishefsky, Crothers, and coworkers (21, 22) . These experiments investigated the cleavage of DNA by the aglycone of calicheamicin (calicheamicinone), which itself was prepared in racemic (23) or in either antipodal (22, 24) form by total synthesis, since it could not be obtained from degrading the natural product. The aglycone was also synthesized in an enantioselective fashion by the Nicolaou group (25) . Danishefsky and Crothers found that calicheamicinone cleaves DNA nonselectively and primarily in a single-9197 strand fashion. Interestingly, the unnatural enantiomer of the aglycone produced a slightly higher ratio of doublestrand to single-strand cleavage than that of the natural enantiomer (22) . From these studies it was concluded that the "sensing" interactions leading to sequence selectivity are due to the aryltetrasaccharide region.
The hypothesis of Danishefsky was supported by subsequent work of Kahne et al. (15) which involved the examination of the cleavage selectivity of a calicheamicin derivative obtained by semisynthesis. This derivative, termed calicheamicin T, contained only the A and E sugar residues. Calicheamicin T exhibited minimal selectivity, implying that the distal residues ofthe aryl-tetrasaccharide are important in recognition.
Several models have been advanced to rationalize the binding of calicheamicin to DNA (26) (27) (28) (29) (30) (31) (32) (33) . One of the earliest was proposed by Schreiber and coworkers (26) , who sought to accurately explain the relative binding orientation of calicheamicin. This model suggests the importance of an interaction between the iodine of calicheaniicin and an amino group of a guanine. Binding studies carried out by Nicolaou (see below) showed that the iodine atom was indeed important for binding and selectivity (29) . However, the specific nature of the contacts made by the iodine is still unclear, since binding sites which do not have a guanine have been identified by the Kahne group (15) . A current view is that a conformational change of DNA is induced upon binding to calicheamicin to accommodate the interactions necessary for selectivity and high affinity (30) (31) (32) (33) . This theory is supported by NMR (27, 30) and CD (31) (35, 36) . Therefore, the only way to obtain this compound for study was by synthesis. The first synthesis of the methyl glycoside of this carbohydrate domain was accomplished by Nicolaou and coworkers (37) . To date, two other syntheses-of the calicheamicin aryltetrasaccharide have been reported (38, 39) . Also, the total synthesis of calicheamicin has been accomplished (40, 41) . The first was a landmark effort by Nicolaou and coworkers (40) that set the standard for future efforts. The total synthesis was also achieved by Danishefsky and coworkers (41), using a highly convergent strategy.
The first evaluations of the synthetic aryl-tetrasaccharide, in complementary investigations by Nicolaou and Danishefsky, revealed that it binds to the same sites and in a similar manner as the parent natural product (29, 42, 43) . Competition experiments by Danishefsky and coworkers (42) revealed that the oligosaccharide will block the cleavage of DNA by calicheamicin at its preferred binding site. Therefore, the major DNA recognition machinery of the drug must reside within the oligosaccharide domain. Additionally, footprinting studies by Nicolaou and coworkers (29, 43) led to the similar conclusion that the oligosaccharide is primarily responsible for the sequence selectivity, although the aglycone most likely confers minor additional selectivity and binding energy. Nicolaou and Joyce (29, 43) have also probed the nature of the iodine-guanine interaction by replacing the iodine with hydrogen, methyl, or other halogens. Each of these compounds has lower affinity for DNA than does the iodide. They conclude that indeed the iodine is involved in binding and selectivity, although the nature of this effect still remains to be unambiguously determined.
With a basic understanding of the mode of binding of calicheamicin in hand, the consortium of Danishefsky, Schreiber, and Crabtree realized the relevance of this information to cell biology (1). That realization was that calicheamicin binding sites are present in the binding sequences of many transcription factors (1). This, along with the knowledge that the methyl glycoside of the calicheamicin oligosaccharide (CLM-MG) binds to sequences similar to those bound by calicheamicin, suggested that the oligosaccharide would block the binding of transcription factors to DNA. This was indeed found to be the case. CLM-MG inhibited the formation of the transcription factor-DNA complexes when the recognition sequence of the protein contained a calicheamicin binding site. That the inhibition of the transcription factor NFAT (44, 45) An in vivo study showed that CLM-MG effectively blocked the expression of a reporter gene under the control ofNFAT, which contains the CLM-MG binding site within its binding sequence. CLM-MG was also found to inhibit the proliferation ofT cells in a dose-dependent manner (1) . This is apparently a direct result ofblocking the formation of transcription factor-DNA complexes.
It was kindly brought to the author's attention that a similar phenomenon was observed by K. C. Nicolaou, P. Vogt, and coworkers (personal communication). This team observed that, in vitro, the calicheamicin carbohydrate domain interferes with the binding of an interleukin-6-dependent transcription factor to its target DNA sequence, within which is the TCCT tract.
The work presented by Danishefsky, Schreiber, Crabtree, and coworkers (1) suggests a new direction for designing DNA-binding agents. Perhaps glycoconjugates such as CLM-MG will be the first step toward new classes of synthetic antiproliferative and immunosuppressive compounds. The chemical synthesis of CLM-MG is also worthy of comment.
The entire oligosaccharide was rapidly constructed from simple glycal building blocks in a modular fashion (46) (47) (48) . The synthetic methodology should also allow the rapid assembly of many other congeners for studying the DNA-binding properties of oligosaccharides and glycoconjugates.
This investigation illustrates the power of combining organic synthesis and cell biology to arrive at solutions to scientific problems. The study was dependent on both organic synthesis, since the intact CLM-MG cannot be obtained in any other way, and cell biology. The work also demonstrates how information obtained from basic research into the synthesis and mechanism ofaction ofnatural products can ultimately lead to insights into how to control cellular processes.
